KaloBios Pharmaceuticals Inc
* KaloBios announces Martin Shkreli’S sale of his stake in the company
* Shkreli continues to be restricted from certain further actions concerning company for a period of time
* Expect to have U.S. Fda pre-ind application meeting within next 6 months to confirm regulatory pathway for benznidazole Source text for Eikon: Further company coverage:
Recent Articles on M&A
